Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
PFE Pfizer
43.790-0.460-1.04%
Close
01/27 16:00 ET
43.890+0.100+0.23%
Post Mkt Price 01/27 19:59 ET
High
44.340
Open
44.220
Turnover
1.05B
Low
43.780
Pre Close
44.250
Volume
23.80M
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Pfizer's Paxlovid Gets European Medicines Agency Recommendation for Standard Marketing Authorization
09:22 AM EST, 01/27/2023 (MT Newswires) -- Pfizer's (PFE) Covid-19 treatment received a recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use to have its c
UBS Group Lowers Pfizer (NYSE:PFE) to Neutral
UBS Group lowered shares of Pfizer (NYSE:PFE – Get Rating) from a buy rating to a neutral rating in a research note published on Thursday, MarketBeat reports. They currently have $47.00 price objecti
Pfizer (PFE) Set to Announce Quarterly Earnings on Tuesday
Pfizer (NYSE:PFE – Get Rating) is set to announce its earnings results before the market opens on Tuesday, January 31st. Analysts expect the company to announce earnings of $1.05 per share for the q
Amazon, Apple, Alphabet Headline Another Busy Earnings Week -- WSJ
By Sabela Ojea Apple Inc., Amazon.com Inc., Meta Platforms Inc. and Alphabet Inc. report earnings in the coming week, four of the many companies providing quarterly updates as layoffs and slowing gro
Pfizer (NYSE:PFE) Stock Rating Lowered by UBS Group
Pfizer (NYSE:PFE – Get Rating) was downgraded by UBS Group from a "buy" rating to a "neutral" rating in a research report issued to clients and investors on Thursday, MarketBeat Ratings reports. They
Preview -- Barron's
Monday 1/30 Franklin Resources, GE HealthCare Technologies, and NXP Semiconductors report quarterly results. Tuesday 1/31 Advanced Micro Devices, Amgen, Caterpillar, Chubb, Edwards Lifesciences, El
EverSource Wealth Advisors LLC Grows Position in Pfizer Inc. (NYSE:PFE)
EverSource Wealth Advisors LLC raised its position in Pfizer Inc. (NYSE:PFE – Get Rating) by 121.3% during the third quarter, according to the company in its most recent 13F filing with the Securiti
Pfizer Inc. (NYSE:PFE) Shares Acquired by Arvest Trust Co. N A
Arvest Trust Co. N A increased its position in Pfizer Inc. (NYSE:PFE – Get Rating) by 7.3% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor own
Pfizer Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) shed 1.04% to $43.79 Friday, on what proved to be an all-around great tra
COVID-19 Omicron Subvariant XBB.1.5 Now Accounts for 61% of Cases Nationwide
Company Overview
More
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
CEO： Dr. Albert Bourla, D.V.M.,PhD
Market： NYSE
Listing Date： 01/17/1944
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet